02.1 Ester vs niacin

Inositol hexanicotinate vs niacin: the ester, the flush and the label

Technical document 02.1 · Reviewed 2026-11-20 · Niacin Inositol Hexanicotinate

On this page
  1. The ester, not a diluted niacin
  2. The flush and the release profile
  3. The niacin arithmetic
  4. What the label has to say
  5. The market question
  6. When to choose the ester

Inositol hexanicotinate is not plain niacin. It is an ester of six nicotinic acid units and one inositol, CAS 6556-11-2, and it carries at most 91.1% niacin by mass. The label has to name the ester, the niacin figure has to be calculated on a stated basis, and a flush statement is a claim that needs support rather than a property of the certificate.

In one line

The ester is a different molecule from niacin: six nicotinic acid units on one inositol, 91.1% niacin by mass, and a label name that has to say so.

The ester, not a diluted niacin

Nicotinic acid is a single pyridine carboxylic acid, CAS 59-67-6, formula C6H5NO2, molecular weight 123.11. Inositol hexanicotinate joins six of those acids to one inositol ring through ester bonds: C42H30N6O12, molecular weight 810.72. The ester is a different molecule, with a different CAS number, a different certificate and a different label name.

Inositol hexanicotinate and nicotinic acid
PropertyInositol hexanicotinateNiacin (nicotinic acid)
CAS number6556-11-259-67-6
FormulaC42H30N6O12C6H5NO2
Molecular weight810.72123.11
Niacin contentUp to 911 mg/g after hydrolysis1,000 mg/g
Water solubilitySlightly solubleSparingly soluble
Assay98.0–101.0% by HPLC99.0–101.0% by titration, dried basis
Label nameInositol hexanicotinateNiacin (nicotinic acid)

The mass difference is the point. A milligram of the ester is not a milligram of niacin, and a formula that substitutes one for the other at the same weight changes the niacin contribution by about 10%.

The flush and the release profile

Immediate-release nicotinic acid is associated with a transient flush in many people, and that response is the reason the ester is chosen for some formulas. The ester releases nicotinic acid slowly as it is hydrolysed, and the EFSA review in 2009 noted that the flush effect is not likely from the ester, while also noting that the data supporting the absence of flushing were limited at the time.

That is a scientific and claims question, not a certificate line. A finished product described as flush-free is making a claim, and the claim has to be supported for the dose and the matrix and reviewed for the destination. The certificate reports the ester, the assay and the impurities; it does not establish how a person will respond. This page makes no flush claim for the material.

The release profile also depends on the dosage form. A capsule disintegrates and releases the powder; a tablet with a modified-release coat changes the rate again. The formulator who needs a particular profile has to test it in the finished product, not infer it from the raw material.

The niacin arithmetic

The conversion factor is fixed by the formula: 6 × 123.11 ÷ 810.72 = 0.9111. A 500 mg weigh-up of the ester delivers at most 455.6 mg of nicotinic acid equivalent. A label that declares 100 mg of niacin needs 109.8 mg of the ester. These are not dose recommendations; they are the sums that keep the label and the weigh-up consistent.

Two cautions follow. First, 91.1% is a theoretical maximum, reached only at complete hydrolysis and full esterification; a lot with free nicotinic acid or a lower ester delivers less. Second, the label may declare the ester mass, the nicotinic acid equivalent or the niacin equivalent, and the three are different figures. The declaration has to say which one it is using, because a reader who assumes the ester mass is niacin mass overstates the intake by about 10%.

On a Supplement Facts panel, niacin is declared in milligrams of niacin equivalents against the 16 mg NE Daily Value, and the source line names the form. In the EU, the nutrient reference value is also 16 mg NE, and the percentage is calculated against it. The ester's contribution to that figure is a regulatory and analytical question, not a fixed multiplication that every market accepts.

What the label has to say

In the EU, the permitted-forms list names “inositol hexanicotinate (inositol hexaniacinate)”, and the label has to use a name that matches the form in the product. “Niacin” alone does not identify the ester, and “vitamin B3” identifies nothing at all. In the US, the Supplement Facts source line should name the ester, for example “Niacin (as inositol hexanicotinate)”, and the name has to match the certificate.

Niacinamide is a third ingredient, not a synonym. It is the amide, CAS 98-92-0, freely soluble and close to neutral in solution, and it has its own label name. A switch from the ester to the amide, or to the acid, is a new specification and a new label; it is not a swap made at the weighing bench. The niacin page and the niacinamide page carry those specifications.

The label also carries the quantity. State whether the number is the ester mass or the nicotinic acid equivalent, and keep the certificate, the specification and the label on the same basis. A label that gives the ester mass but the analyst's report in niacin equivalent invites a dose error that no certificate can correct.

The market question

The EU list, the EFSA opinion and the US dietary-supplement route are three different documents. The EU list names the form; the EFSA opinion describes the ester as a niacin source and derives a use level of about 11 mg/day from the 10 mg/day nicotinic acid upper safe level; the US route uses the dietary-ingredient framework and applies the Supplement Facts rules. A product at a higher ester dose sits between those positions, and the buyer's regulatory team has to confirm how the destination reads it.

The UK adds a fourth file. Great Britain uses the retained lists and the GB register; Northern Ireland follows the EU framework. The delivery address decides which applies, and the label and the entry cited have to match that decision.

The compliance page sets out the documents and the checks; the identity page covers the tests that prove the ester. The methods library describes the HPLC and IR work, and the quality page describes the release workflow.

When to choose the ester

Choose inositol hexanicotinate when the brief calls for the ester, the label can carry that name, and the niacin arithmetic has been done on the ester basis. Choose plain niacin when the label says niacin (nicotinic acid), the formula can carry the acid, and the immediate-release profile is acceptable. Choose niacinamide when the formula needs a freely soluble, near-neutral B3 source and the label can name the amide.

The three are not interchangeable, and a late switch is a labelling event as well as a formulation one. The product hub carries the catalog specification for the ester, and the grade page places this comparison in the wider B3 range.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation